Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controls.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
10 2022
Historique:
received: 15 10 2021
accepted: 27 06 2022
revised: 15 06 2022
pubmed: 28 7 2022
medline: 7 12 2022
entrez: 27 7 2022
Statut: ppublish

Résumé

Probing naturally-occurring, reciprocal genomic copy number variations (CNVs) may help us understand mechanisms that underlie deviations from typical brain development. Cross-sectional studies have identified prominent reductions in cortical surface area (SA) and increased cortical thickness (CT) in 22q11.2 deletion carriers (22qDel), with the opposite pattern in duplication carriers (22qDup), but the longitudinal trajectories of these anomalies-and their relationship to clinical symptomatology-are unknown. Here, we examined neuroanatomic changes within a longitudinal cohort of 261 22q11.2 CNV carriers and demographically-matched typically developing (TD) controls (84 22qDel, 34 22qDup, and 143 TD; mean age 18.35, ±10.67 years; 50.47% female). A total of 431 magnetic resonance imaging scans (164 22qDel, 59 22qDup, and 208 TD control scans; mean interscan interval = 20.27 months) were examined. Longitudinal FreeSurfer analysis pipelines were used to parcellate the cortex and calculate average CT and SA for each region. First, general additive mixed models (GAMMs) were used to identify regions with between-group differences in developmental trajectories. Secondly, we investigated whether these trajectories were associated with clinical outcomes. Developmental trajectories of CT were more protracted in 22qDel relative to TD and 22qDup. 22qDup failed to show normative age-related SA decreases. 22qDel individuals with psychosis spectrum symptoms showed two distinct periods of altered CT trajectories relative to 22qDel without psychotic symptoms. In contrast, 22q11.2 CNV carriers with autism spectrum diagnoses showed early alterations in SA trajectories. Collectively, these results provide new insights into altered neurodevelopment in 22q11.2 CNV carriers, which may shed light on neural mechanisms underlying distinct clinical outcomes.

Identifiants

pubmed: 35896619
doi: 10.1038/s41380-022-01681-w
pii: 10.1038/s41380-022-01681-w
pmc: PMC9718681
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4181-4190

Subventions

Organisme : NIMH NIH HHS
ID : K01 MH112774
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085953
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Cereb Cortex. 2009 Nov;19(11):2728-35
pubmed: 19299253
Brain Res. 1979 Mar 16;163(2):195-205
pubmed: 427544
Cereb Cortex. 2021 Jun 10;31(7):3285-3298
pubmed: 33638978
Genet Med. 2008 Apr;10(4):267-77
pubmed: 18414210
Psychol Med. 2022 Jul;52(9):1698-1709
pubmed: 33019960
Eur J Med Genet. 2008 Nov-Dec;51(6):501-10
pubmed: 18707033
Cereb Cortex. 2020 Mar 14;30(3):1548-1558
pubmed: 31670797
Science. 1986 Apr 11;232(4747):232-5
pubmed: 3952506
J Neurosci. 2004 Sep 22;24(38):8223-31
pubmed: 15385605
Cereb Cortex. 2015 Oct;25(10):3977-93
pubmed: 25452572
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20750-20759
pubmed: 31548375
Front Hum Neurosci. 2010 Jan 08;3:68
pubmed: 20161700
Lancet Psychiatry. 2019 Jun;6(6):493-505
pubmed: 31056457
PLoS Genet. 2011 Nov;7(11):e1002334
pubmed: 22102821
Nat Genet. 2017 Jan;49(1):27-35
pubmed: 27869829
Genet Med. 2001 Jan-Feb;3(1):79-84
pubmed: 11339385
Nat Rev Dis Primers. 2015 Nov 19;1:15071
pubmed: 27189754
Neuroimage. 2020 Oct 15;220:117129
pubmed: 32640273
JAMA Psychiatry. 2019 Aug 1;76(8):818-825
pubmed: 30994872
Mol Psychiatry. 2021 Dec;26(12):7671-7678
pubmed: 34253864
Stat Methods Med Res. 1995 Sep;4(3):187-96
pubmed: 8548102
Genome Res. 2007 Apr;17(4):482-91
pubmed: 17351135
Mol Psychiatry. 2020 Aug;25(8):1704-1717
pubmed: 31925327
Biol Psychiatry. 2011 May 15;69(10):945-52
pubmed: 21195387
Res Dev Disabil. 2009 Jul-Aug;30(4):763-73
pubmed: 19070990
Trends Neurosci. 1995 Sep;18(9):383-8
pubmed: 7482803
Biol Psychiatry. 2016 Aug 15;80(4):331-337
pubmed: 26795442
Curr Psychiatry Rep. 2008 Apr;10(2):148-57
pubmed: 18474208
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1060-1068
pubmed: 19797984
Cell. 2012 Mar 16;148(6):1223-41
pubmed: 22424231
JAMA Psychiatry. 2021 Jul 1;78(7):753-766
pubmed: 33950164
J Neurosci. 2017 Mar 22;37(12):3402-3412
pubmed: 28242797
Biol Psychiatry. 2020 Aug 1;88(3):260-272
pubmed: 32143830
Psychol Med. 2018 Oct;48(14):2375-2383
pubmed: 29338796
Schizophr Res. 2017 Oct;188:35-41
pubmed: 27988073
Neurosci Biobehav Rev. 2019 Dec;107:143-153
pubmed: 31493414
Brain Imaging Behav. 2014 Jun;8(2):153-82
pubmed: 24399358
Mol Psychiatry. 2013 Nov;18(11):1153-65
pubmed: 23917946
Neuroimage. 2010 Nov 15;53(3):1135-46
pubmed: 20006715
Am J Psychiatry. 2020 Jul 1;177(7):589-600
pubmed: 32046535
JAMA Psychiatry. 2017 Jul 1;74(7):757-758
pubmed: 28514462
Am J Psychiatry. 2014 Jun;171(6):627-39
pubmed: 24577245
Am J Hum Genet. 2003 Nov;73(5):1027-40
pubmed: 14526392
Schizophr Res. 2009 Dec;115(2-3):182-90
pubmed: 19836927
Mol Psychiatry. 2014 Jan;19(1):37-40
pubmed: 24217254
Neuroimage. 2020 Mar;208:116450
pubmed: 31821869
Neuroimage. 2015 Jan 1;104:138-45
pubmed: 25312772
Sleep. 2021 Oct 11;44(10):
pubmed: 33971013
J Child Psychol Psychiatry. 2017 Mar;58(3):305-314
pubmed: 27786353
Hum Brain Mapp. 2016 Jun;37(6):2027-38
pubmed: 26946457
Neuroimage. 2014 Feb 15;87:120-6
pubmed: 24246495
Transl Psychiatry. 2018 Apr 18;8(1):85
pubmed: 29666363
Eur J Med Genet. 2009 Mar-Jun;52(2-3):88-93
pubmed: 19254783
JAMA Psychiatry. 2016 Sep 1;73(9):963-969
pubmed: 27602560
J Neurosci. 2011 May 11;31(19):7174-7
pubmed: 21562281
Biol Psychiatry. 2015 Jan 15;77(2):147-57
pubmed: 25034946
Neurology. 2001 Jul 24;57(2):245-54
pubmed: 11468308
J Neurosci. 2017 Jun 28;37(26):6183-6199
pubmed: 28536274
J Psychiatr Res. 2011 Mar;45(3):322-31
pubmed: 20817203
Biol Psychiatry. 2017 Oct 1;82(7):511-521
pubmed: 28274468
Biol Psychiatry. 2020 Jan 15;87(2):150-163
pubmed: 31500805
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Feb;6(2):211-224
pubmed: 33218931
Am J Med Genet B Neuropsychiatr Genet. 2013 Oct;162B(7):751-61
pubmed: 24132907
Cereb Cortex. 2010 Jun;20(6):1332-40
pubmed: 19819933
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671
Lancet Psychiatry. 2018 Jul;5(7):573-580
pubmed: 29886042
Mol Autism. 2016 May 06;7:27
pubmed: 27158440

Auteurs

Maria Jalbrzikowski (M)

Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Amy Lin (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Neuroscience Interdepartmental Program, University of California, Los Angeles, CA, USA.

Ariana Vajdi (A)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.

Vardui Grigoryan (V)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.

Leila Kushan (L)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.

Christopher R K Ching (CRK)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Charles Schleifer (C)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Neuroscience Interdepartmental Program, University of California, Los Angeles, CA, USA.

Rebecca A Hayes (RA)

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Stephanie A Chu (SA)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Neuroscience Interdepartmental Program, University of California, Los Angeles, CA, USA.

Catherine A Sugar (CA)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Department of Biostatistics, University of California, Los Angeles, CA, USA.

Jennifer K Forsyth (JK)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
Department of Psychology, University of Washington, Seattle, WA, USA.

Carrie E Bearden (CE)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA. cbearden@mednet.ucla.edu.
Neuroscience Interdepartmental Program, University of California, Los Angeles, CA, USA. cbearden@mednet.ucla.edu.
Department of Psychology, University of California, Los Angeles, CA, USA. cbearden@mednet.ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH